Director/PDMR Shareholding
Source: RNS
20 October 2020
Collagen Solutions plc
(the "Company")
Director/PDMR Dealing
1. Exercise of options in connection with Rule 15 proposals made under the UK City Code on Takeovers and Mergers (the "Code")
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that, on 20 October 2020, the executive directors and other persons discharging managerial responsibility ("PDMRs") set out in the table below acquired ordinary shares of 1 pence each in the share capital of the Company ("Shares") pursuant to the exercise of options originally granted under the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme ("EMI Scheme") and the Collagen Solutions plc Deferred Bonus Plan ("DBP").
Each of these exercises:
· was in accordance with proposals made by Rosen's Diversified, Inc. ("RDI") to participants in the EMI Scheme and the DBP under Rule 15 of the Code (the "Rule 15 Proposals") in connection with its recommended cash offer (the "Offer") to acquire the entire issued and to be issued ordinary share capital of the Company not already owned by RDI; and
· became effective on the Offer being declared unconditional in all respects (as stated by RDI in its announcement this morning).
|
Director/PDMR |
Position |
Aggregate number of Shares acquired on 20 October 2020 |
|
Jamal Rushdy |
Chief Executive Officer |
3,725,000 |
|
Lou Ruggiero |
Chief Business Officer |
4,100,000 |
|
Hilary Spence |
Chief Financial Officer |
4,336,000 |
|
Brad Selman |
PDMR / VP Global Sales and Marketing |
700,000 |
|
Chris Wattengel |
PDMR / VP Global R&D |
1,250,000 |
|
Kevin Darling |
PDMR / VP Tissue Products |
1,250,000 |
Notes:
1 Details of the prices per Share paid by the individuals in connection with these exercises are set out in the tables at the end of this announcement.
The Shares required to satisfy the above exercises (which, in accordance with the terms of the Rule 15 Proposals, will be assented to the Offer) are sourced from the Collagen Solutions plc Employee Benefit Trust.
2. Surrender of underwater options
The Company also announces that, on 18 October 2020, it received a notification from Jamal Rushdy (Chief Executive Officer) that he had elected to surrender, for no consideration, options to acquire a total of 6,000,000 Shares that had previously been granted to him pursuant to the EMI Scheme but which had an exercise price in excess of the 6.5p per Share consideration payable under the Offer.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
|
a) |
Name |
Jamal Rushdy |
|||||||||
|
2 |
Reason for the notification |
||||||||||
|
a) |
Position/status |
Chief Executive Officer |
|||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||
|
b) |
Nature of the transaction |
Surrender of "underwater" options over Shares granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||
|
e) |
Date of the transaction |
2020-10-18 |
|||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||
|
a) |
Name |
Lou Ruggiero |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
Chief Business Officer |
|||||||||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||
|
a) |
Name |
Hilary Spence |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
Chief Financial Officer |
|||||||||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc Deferred Bonus Plan |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
|
a) |
Name |
Brad Selman |
|||||||||
|
2 |
Reason for the notification |
||||||||||
|
a) |
Position/status |
PDMR / VP Global Sales and Marketing |
|||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
|
a) |
Name |
Chris Wattengel |
|||||||||
|
2 |
Reason for the notification |
||||||||||
|
a) |
Position/status |
PDMR / VP Global R&D |
|||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||
|
a) |
Name |
Kevin Darling |
|||||||||
|
2 |
Reason for the notification |
||||||||||
|
a) |
Position/status |
PDMR / VP Tissue Products |
|||||||||
|
b) |
Initial notification/ Amendment |
Initial Notification |
|||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a) |
Name |
Collagen Solutions plc |
|||||||||
|
b) |
LEI |
213800IFY1CVGRGETL95 |
|||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each ("Shares") |
|||||||||
|
Identification code |
ISIN Code: GB00B94T6Y14 |
||||||||||
|
b) |
Nature of the transaction |
Acquisition of Shares on the exercise of options granted pursuant to the Collagen Solutions plc 2014 Enterprise Management Incentive Scheme |
|||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
Not applicable |
|||||||||
|
e) |
Date of the transaction |
2020-10-20 |
|||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
|||||||||
Enquiries:
|
Collagen Solutions Plc |
Contact via Walbrook |
|
Jamal Rushdy, CEO |
|
|
Hilary Spence, CFO |
|
|
|
|
|
Cenkos Securities plc (Nominated Adviser and Broker) |
|
|
Giles Balleny (Corporate Finance) |
Tel: 0207 397 8900 |
|
Stephen Keys |
|
|
|
|
|
Walbrook PR |
Tel: 020 7933 8780 or collagen@walbrookpr.com |
|
Anna Dunphy |
Mob: 07876 741 001 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
